C3.ai
AI · NYSE
About AI
- Employees
- 1,181
- Headquarters
- Redwood City, California
- Listed
- Dec 9, 2020
- Sector
- Information Technology
- Industry
- Software
- Website
- c3.ai
AI key statistics
- Market cap
- 1.77B
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 5.07M
- Volume
- 2.60M
- Open price
- $11.30
- High today
- $11.82
- Low today
- $11.16
- 52 Week high
- $19.60
- 52 Week low
- $7.68
C3.ai (AI) at a glance
As of Oct 20, 2026, C3.ai (AI) shares are priced at $11.69, giving the company a market cap of 1.77B and a price-to-earnings ratio of 0.00.
Today the stock has traded between $11.16 and $11.82. The current price is 4.7% above the day's low and 1.1% below its high.
Volume so far is 2.60M shares, below the average of 5.07M shares a day.
Over the past year C3.ai has ranged from $7.68 to $19.60, and now sits 34% of the way up that range.
C3.ai met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY27 it reported -$0.20 per share against an estimate of -$0.2685.
The average analyst price target is $9.38, 19.7% below the current price, from 13 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy23.1%
- Hold46.2%
- Sell30.8%
- Low
- $6.06
- Now
- $11.69
- High
- $15.75
AI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 34.2% on average.
- Q2 FY25: reported -$0.06 per share against an estimate of -$0.1669
- Q3 FY25: reported -$0.12 per share against an estimate of -$0.2576
- Q4 FY25: reported -$0.16 per share against an estimate of -$0.2069
- Q1 FY26: reported -$0.37 per share against an estimate of -$0.2033
- Q2 FY26: reported -$0.25 per share against an estimate of -$0.3363
- Q3 FY26: reported -$0.40 per share against an estimate of -$0.2975
- Q4 FY26: reported -$0.33 per share against an estimate of -$0.384
- Q1 FY27: reported -$0.20 per share against an estimate of -$0.2685
AI news
- Press releaseBusiness Wire
- Avi Kapoor
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
- Dylan Berman
C3.Ai Shares Edges Higher Monday: What's Going On?
- Lekha Gupta
Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More
- Priya Nigam
C3.ai Stock Rises: Analysts See Progress, But Risks Remain
- Dylan Berman
C3.Ai Stock In Focus: Reports Q1 Double Beat — Then Guides Below Estimates
- Erica Kollmann
C3.ai Reports Strong Q1: Turnaround is On Track, CEO Says
- Press releaseBusiness Wire
C3 AI Announces Fiscal First Quarter 2027 Results
Similar companies
Companies in the same industry as C3.ai
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- SDSTStardust Power$0.02−23.66%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.